CN Patent
CN102724965A — 含羧乙烯基聚合物的纳米颗粒混悬液
Assigned to Alcon Research Co ltd · Expires 2012-10-10 · 14y expired
What this patent protects
本发明涉及含有羧乙烯基聚合物(例如卡波姆)、半乳甘露聚糖(例如瓜尔豆胶)和硼酸/硼酸盐化合物的混悬液组合物。该组合物中还包含难溶性颗粒化合物(例如奈帕芬胺)。该难溶性颗粒化合物的粒度小,从而增强该化合物的生物利用度。
USPTO Abstract
本发明涉及含有羧乙烯基聚合物(例如卡波姆)、半乳甘露聚糖(例如瓜尔豆胶)和硼酸/硼酸盐化合物的混悬液组合物。该组合物中还包含难溶性颗粒化合物(例如奈帕芬胺)。该难溶性颗粒化合物的粒度小,从而增强该化合物的生物利用度。
Drugs covered by this patent
- Nevanac (NEPAFENAC) · Harrow Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.